Number 533 (Reaffirmed 2019)
Committee on Obstetric Practice
This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed.
Abstract: Prenatal lead exposure has known adverse effects on maternal health and infant outcomes across a wide range of maternal blood lead levels. Adverse effects of lead exposure are being identified at lower levels of exposure than previously recognized in both children and adults. In 2010, the Centers for Disease Control and Prevention issued the first guidelines regarding the screening and management of pregnant and lactating women who have been exposed to lead.
Prenatal lead exposure has known adverse effects on maternal health and infant outcomes across a wide range of maternal blood lead levels 1. Adverse effects of lead exposure are being identified at lower levels of exposure than previously recognized in both children and adults 2 3 4 5 6 7. In 2010, the Centers for Disease Control and Prevention issued the first guidelines regarding the screening and management of pregnant and lactating women who have been exposed to lead 8.
Environmental policies and public health education programs have led to significant reductions in cases of lead exposure in the United States 9. Despite these improvements, approximately 1% of women of childbearing age (15–49 years) have blood lead levels greater than or equal to 5 micrograms/dL 8.
Although no threshold has been found to trigger the adverse health effects of lead 8, in nonpregnant adults blood lead levels less than 5 micrograms/dL are considered normal, blood lead levels between 5 micrograms/dL and 10 micrograms/dL require follow-up, and blood lead levels greater than 10 micrograms/dL are managed with environmental assessment and abatement of exposures. Chelation therapy is considered at blood lead levels greater than 40 micrograms/dL for symptomatic individuals, and levels greater than 70 micrograms/dL are considered a medical emergency. In children, treatment is recommended at blood lead levels of 45 micrograms/dL or greater.
The main target for lead toxicity is the nervous system, both in adults and children 10. High levels of exposure can result in delirium, seizures, stupor, coma, or even death. Other overt signs and symptoms of lead toxicity may include hypertension, peripheral neuropathy, ataxia, tremor, headache, loss of appetite, weight loss, fatigue, muscle and joint aches, changes in behavior and concentration, gout, nephropathy, lead colic, and anemia. Health effects of chronic low-level exposure in adults include cognitive decline, hypertension and other cardiovascular effects, decrements in renal function, and adverse reproductive outcome. The developing nervous systems in children make them more susceptible to the neurologic effects of lead toxicity.
Adverse Health Effects of Prenatal Exposure
Lead readily crosses the placenta by passive diffusion and has been detected in the fetal brain as early as the end of the first trimester 8. Elevated lead levels in pregnancy have been associated with several adverse outcomes, including gestational hypertension, spontaneous abortion, low birth weight, and impaired neurodevelopment 11 12 13 14.
Lead exposure has been associated with an increased risk of gestational hypertension, but the magnitude of the effect, the exposure level at which risk begins to increase, and whether risk is most associated with acute or cumulative exposure remain uncertain. Also, it is unclear whether lead-induced increases in blood pressure during pregnancy lead to severe hypertension or preeclampsia 11 15 16 17 18.
Evidence shows that maternal exposure to high levels of lead increases the risk of spontaneous abortion 19. However, data for an association between low or moderate lead levels and spontaneous abortion are inconsistent. The strongest available evidence comes from a prospective study of 668 pregnant women in Mexico City that demonstrated a statistically significant dose–response relationship between low-to-moderate maternal blood lead levels and the risk of spontaneous abortion 12. Yet, another longitudinal study of 351 women in Japan showed no difference in blood lead levels between spontaneous abortion cases (n=15) and ongoing pregnancies 20. Larger prospective studies are needed to further clarify the effects of low and moderate levels of lead on spontaneous abortion risk.
More recent and well-designed studies suggest that maternal lead exposure during pregnancy is inversely related to fetal growth, as reflected by duration of pregnancy and infant size. One study that used a registry-based approach found that offspring of mothers occupationally exposed to lead had an increased risk of low birth weight (relative risk [RR], 1.34; confidence interval [CI], 1.12–1.6) compared with infants of women not exposed to lead 13. A case–control study in Mexico City found umbilical cord blood lead levels to be higher in preterm infants (mean value, 9.8 micrograms/dL) compared with term infants (mean value, 8.4 micrograms/dL) 21. A birth cohort study, also conducted in Mexico City, found maternal bone lead burden to be inversely related to offspring weight 22, length, and head circumference at birth 23.
A large number of studies provide evidence that prenatal lead exposure impairs children’s neurodevelopment. Some prospective studies have included children with low levels of prenatal lead exposure and continue to detect inverse associations with neurodevelopment, although these data are less consistent than those related to the high levels of lead exposure. In one study, each 1 microgram/dL increase in umbilical cord blood lead was found to be associated with a reduction of 0.6 points in the mental development index scores of the Bayley Scales of Infant Development at age 3 months, with similar results at age 6 months 14 24. However, another prospective cohort study found that the relationship between prenatal blood lead levels and early childhood IQ is not linear, with the strongest postnatal effects noted at low levels of prenatal exposure 25. The available data are inadequate to establish the presence or absence of an association between maternal lead exposure and major congenital anomalies in the fetus.
Lead Exposure During Breastfeeding
Although the benefits of breastfeeding generally outweigh the risks of environmental exposure, the effects of breastfeeding on infant lead levels have been studied. Lead has been detected in the breast milk of women in population-based studies; however, the availability of high-quality data to assess the risk for toxicity to the breastfeeding infant is limited 8. Although infant blood lead levels have been correlated with the duration of breastfeeding 26, the ratio of breast milk lead levels to blood lead levels has been found to be less than 3% 27. According to the American Academy of Pediatrics, because of the contribution of lead levels found in infant formula and other infant foods, breastfed infants of mothers with normal blood lead levels are actually exposed to slightly less lead than if they were not breastfed 28.
Screening and Management
The Centers for Disease Control and Prevention (CDC) and the American College of Obstetricians and Gynecologists do not recommend blood lead testing of all pregnant women in the United States. Obstetric health care providers should consider the possibility of lead exposure in individual pregnant women by evaluating risk factors for exposure as part of a comprehensive health risk assessment and perform blood lead testing if a single risk factor is identified. Assessment of lead exposure should take place at the earliest contact with the pregnant patient.
Important risk factors for lead exposure in pregnant women are listed in Box 1. Lead-based paint is less likely to be an important exposure source for pregnant women than it is for children, except during renovation or remodeling in older homes. Women should take precautions when repainting surfaces with deteriorated paint or performing any remodeling or renovation work that disturbs painted surfaces, such as scraping off paint or tearing out walls 8.
For pregnant women with blood lead levels of 5 micrograms/dL or higher, sources of lead exposure should be identified and women should receive counseling regarding avoidance of further exposure. Confirmatory and follow-up blood lead testing should be performed in accordance with the CDC’s recommended schedules Table 1 and maternal or umbilical cord blood lead levels should be measured at delivery 8. Women with confirmed blood lead levels of 45 micrograms/dL or more should be treated in consultation with clinicians experienced in the management of lead toxicity and high-risk pregnancy. Once the source of lead exposure is identified and eliminated, the initial decrease in blood lead level occurs relatively rapidly because of lead’s short (35-day) initial half-life in blood 29. This initial rapid decrease is followed by a slow, continuous decrease over several months to several years because of mobilization of lead from stores in the bone 8. Recommendations for the frequency of blood lead follow-up tests are included in Table 1.
Adequate dietary intake of calcium, iron, zinc, vitamin C, vitamin D, and vitamin E is known to decrease lead absorption 30 31. Iron-deficiency anemia is associated with elevated blood lead levels and may increase lead absorption. During pregnancy and lactation, lead from prior exposures can be mobilized from bones because of the increased bone turnover. Pregnant and lactating women with a current or past blood lead level of 5 micrograms/dL or higher should receive specific nutritional recommendations regarding calcium and iron supplementation. A balanced diet that contains 2,000 mg of calcium and 60–120 mg of iron daily is recommended 8. This can be achieved through either food intake or supplementation. Supplements should be divided into doses of 500 mg of calcium and 60 mg of iron to improve absorption.
Risk Factors for Lead Exposure in Pregnant and Lactating Women
Recent emigration from or residency in areas where ambient lead contamination is high—women from countries where leaded gasoline is still being used (or was recently phased out) or where industrial emissions are not well controlled.
Living near a point source of lead—examples include lead mines, smelters, or battery recycling plants (even if the establishment is closed).
Working with lead or living with someone who does—women who work in or who have family members who work in an industry that uses lead (eg, lead production, battery manufacturing, paint manufacturing, ship building, ammunition production, or plastic manufacturing).
Using lead-glazed ceramic pottery—women who cook, store, or serve food in lead-glazed ceramic pottery made in a traditional process and usually imported by individuals outside the normal commercial channels.
Eating nonfood substances (pica) —women who eat or mouth nonfood items that may be contaminated with lead, such as soil or lead-glazed ceramic pottery.
Using alternative or complementary substances, herbs, or therapies—women who use imported home remedies or certain therapeutic herbs traditionally used by East Indian, Indian, Middle Eastern, West Asian, and Hispanic cultures that may be contaminated with lead.
Using imported cosmetics or certain food products—women who use imported cosmetics, such as kohl or surma or certain imported foods or spices that may be contaminated with lead.
Engaging in certain high-risk hobbies or recreational activities—women who engage in high-risk activities (eg, stained glass production or pottery making with certain leaded glazes and paints) or have family members who do.
Renovating or remodeling older homes without lead hazard controls in place—women who have been disturbing lead paint, creating lead dust, or both or have been spending time in such a home environment.
Consumption of lead-contaminated drinking water—women whose homes have leaded pipes or source lines with lead.
Having a history of previous lead exposure or evidence of elevated body burden of lead—women who may have high body burdens of lead from past exposure, particularly those who have deficiencies in certain key nutrients (calcium or iron).
Living with someone identified with an elevated lead level—women who may have exposure in common with a child, close friend, or other relative living in the same environment.
Modified from Centers for Disease Control and Prevention. Guidelines for the identification and management of lead exposure in pregnant and lactating women. Atlanta (GA): CDC; 2010. Available at: http://www.cdc.gov/nceh/lead/publications/leadandpregnancy2010.pdf. Retrieved March 7, 2012.
Women with risk factors for elevated lead levels Box 1 who have not been screened during pregnancy should be screened postpartum if they plan to breastfeed. Initiation of breastfeeding should be encouraged postpartum in a woman with a blood lead level less than 40 micrograms/dL. A woman with a confirmed blood lead level of 40 micrograms/dL or higher should not initiate breastfeeding and should be advised to pump and discard her breast milk until her blood lead level has decreased to less than 40 micrograms/dL. Blood lead measurements should be repeated every 1–2 weeks after the source of exposure has been identified and removed. At maternal blood lead levels of 5–39 micrograms/dL, breastfeeding should be initiated and accompanied by sequential testing of infant blood lead levels to monitor trends. If the infant’s blood lead level is greater than 5 micrograms/dL, breastfeeding should be discontinued until the maternal blood lead level decreases. If no external source is identified, and the maternal blood lead level is greater than 20 micrograms/dL and the infant blood lead level is 5 micrograms/dL or more, breast milk should be suspected as the source and temporary interruption of breastfeeding until the maternal blood lead level decreases should be considered.
In addition to removing the source of lead exposure for the mother and infant, several nutritional interventions have been studied. Calcium supplementation (1,200 mg daily) has been associated with a 5–10% decrease in breast milk lead levels among women over the course of lactation 31 32 33 34, suggesting that calcium supplementation also may be an intervention strategy to reduce lead in breast milk from both current and previously accumulated sources. Among women in the postpartum period, increased intakes of vitamin C also have been associated with decreased levels of lead in breast milk.
Conclusions and Recommendations
Routine blood lead testing of all pregnant women is not recommended.
Risk assessment of lead exposure should take place at the earliest contact with pregnant or lactating women, and blood lead testing should be performed if a single risk factor is identified Box 1.
Elevated lead levels in pregnancy have been associated with gestational hypertension, spontaneous abortion, low birth weight, and impaired neurodevelopment.
Prenatal lead exposure has known adverse effects on maternal health and infant outcomes across a wide range of maternal blood lead levels.
Pregnant women with blood lead levels of 5 micrograms/dL or higher should be treated as follows:
Sources of lead exposure should be identified.
Women should receive counseling regarding avoidance of further exposure and receive specific nutritional recommendations regarding calcium and iron supplementation because these strategies can decrease their lead levels.
Confirmatory and follow-up blood lead testing should be performed in accordance with the CDC’s recommended schedules Table 1.
Women with confirmed blood lead levels of 45 micrograms/dL or more should be treated in consultation with clinicians experienced in the management of lead toxicity and high-risk pregnancy.
Initiation of breastfeeding should be encouraged postpartum in a woman with a blood lead level less than 40 micrograms/dL.
A breastfeeding woman with a confirmed blood lead level of 40 micrograms/dL or higher should be advised to pump and discard her breast milk until her blood lead level has decreased to less than 40 micrograms/dL.
If no external source is identified, and the maternal blood lead level is greater than 20 micrograms/dL and the infant blood lead level is 5 micrograms/dL or more, breast milk should be suspected as the source and temporary interruption of breastfeeding until the maternal blood lead level decreases should be considered.